Merck Research Laboratories articles over last 30 days

- articles last 30 days - articles per day
Mentioned in this news Places Companies People
2014/12/13 10:15
2014/12/13 10:15
5d
Information contained on this page is provided by an independent third-party content provider. WorldNow and this Station make no warranties or representations in connection therewith. If you have any...
2014/12/13 10:15
2014/12/13 10:15
Latest videos
2014/12/10 15:06
2014/12/10 15:06
8d
Cubist Pharmaceuticals Inc.’s big payoff for its investments in developing antibiotics is a bright spot in a field without much good news for patients and their doctors. Merck & Co.’s $8.4 billion...
2014/12/09 23:44
2014/12/09 23:44
8d
It’s a long commute from Solana Beach to Silicon Valley, but it’s one Dr. Carrolee Barlow is willing to make for the chance to lead one of the nation’s premiere research institutes on Parkinson’s...
2014/12/07 18:08
2014/12/07 18:08
11d
Overall Response Rate of 66 Percent Observed in Pembrolizumab-treated Patients Whose Cancer Progressed on Brentuximab Vedotin Phase 2 Study Planned for the First Half of 2015 (KEYNOTE-087) Merck,...
2014/12/06 18:17
2014/12/06 18:17
12d
SAN FRANCISCO--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, announced today early study findings demonstrating that KEYTRUDA® (pembrolizumab), the company’s...
2014/11/20 15:28
2014/11/20 15:28
28d
Fred Hutchinson Cancer Center names new president SEATTLE – Fred Hutchinson Cancer Research Center has named an internationally renowned expert in cancer genetics and precision medicine as its new...
2014/11/17 01:17
2014/11/17 01:17
1m
ZURICH--(BUSINESS WIRE)--MSD, plus connu sous l’appellation Merck aux États-Unis et au Canada, a annoncé aujourd’hui qu’une analyse prédéterminée des données expérimentales de l’étude pivot de phase 2...
2014/11/17 01:17
2014/11/17 01:17
1m
ZÜRICH--(BUSINESS WIRE)--MSD, in den USA und Kanada als Merck firmierend, meldete heute, dass die vorgegebene Analyse der Untersuchungsdaten einer zulassungsrelevanten Phase-2-Studie (KEYNOTE-002) mit...
2014/11/16 19:17
2014/11/16 19:17
1m
ZURIGO--(BUSINESS WIRE)--MSD, conosciuta negli Stati Uniti e in Canada con il nome di Merck, ha oggi annunciato che un'analisi predeterminata di dati sperimentali di uno studio registrativo di fase 2...
2014/11/16 19:17
2014/11/16 19:17
1m
ZÜRICH--(BUSINESS WIRE)--MSD, in de Verenigde Staten en Canada bekend onder de naam Merck, heeft vandaag bekendgemaakt dat een voorgespecificeerde analyse van onderzoeksgegevens uit een pivotaal Fase...
2014/11/16 10:17
2014/11/16 10:17
m
ZURICH--(BUSINESS WIRE)--MSD, known as Merck in the United States and Canada, announced today that a pre-specified analysis of investigational data from a pivotal Phase 2 study (KEYNOTE-002) showed...
2014/12/13 10:15
2014/12/13 10:15
Latest from Twitter